REDUCTION IN MYOCARDIAL INFARCTION SIZE

摘要

This invention provides methods and compositions used for reducing the Myocardial Infarct (MI) size in diabetic subjects exhibiting the haptoglobin (Hp) 2 allele. Specifically, the invention relates to reduction of MI in diabetic subjects carrying the Hp-2 allele by reducing the oxidative sterss in these subjects following ischemia-reperfusion injury.